机译:加速与标准同步蛋白,然后是环磷酰胺,甲氨蝶呤和氟尿嘧啶或Capecitabine作为随机核肉2试验中的乳腺癌辅助治疗(CRUK / 05/19):多期,第3阶段,开放标签,随机,受控试验
Univ Edinburgh MRC Inst Genet &
Mol Med Canc Res UK Edinburgh Ctr Edinburgh Midlothian Scotland;
Inst Canc Res ICR CTSU Div Clin Studies London England;
Beatson Hosp Dept Oncol Glasgow Lanark Scotland;
Univ Leeds St James Inst Oncol Leeds W Yorkshire England;
Weston Pk Hosp Dept Oncol Sheffield S Yorkshire England;
Inst Canc Res ICR CTSU Div Clin Studies London England;
Shrewsbury &
Telford Hosp NHS Trust Dept Oncol Shrewsbury Salop England;
Singleton Hosp Dept Oncol Swansea W Glam Wales;
Royal Sussex Cty Hosp Dept Oncol Brighton E Sussex England;
Royal Stoke Univ Hosp Dept Oncol Stoke On Trent Staffs England;
Addenbrookes Hosp Dept Oncol Cambridge England;
Guys &
St Thomas NHS Fdn Trust Dept Oncol London England;
Univ Birmingham Canc Res UK Clin Trials Unit Birmingham W Midlands England;
Inst Canc Res ICR CTSU Div Clin Studies London England;
Univ Leeds Clin Trials Res Unit Leeds W Yorkshire England;
Royal Surrey Cty Hosp Dept oncol Guildford Surrey England;
Southampton Gen Hosp Dept Oncol Southampton Hants England;
Canc Clin Trials Unit Scotland CaCTUS Glasgow Lanark Scotland;
NIHR Univ Coll London Hosp Biomed Res Ctr Dept Oncol London England;
Freeman Rd Hosp Dept Oncol Northern Ctr Canc Care Newcastle Upon Tyne Tyne &
Wear England;
Christie Hosp Dept Oncol Manchester Lancs England;
Velindre NHS Trust Dept Oncol Cardiff S Glam Wales;
Inst Canc Res ICR CTSU Div Clin Studies London England;
机译:加速与标准同步蛋白,然后是环磷酰胺,甲氨蝶呤和氟尿嘧啶或Capecitabine作为随机核肉2试验中的乳腺癌辅助治疗(CRUK / 05/19):多期,第3阶段,开放标签,随机,受控试验
机译:佐剂卡培他滨与多西紫杉醇和环磷酰胺加上二阴性乳腺癌的同性全酶(CBCSG010)组合(CBCSG010):开放标签,随机,多期,第3阶段试验
机译:奥沙利铂,氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸在术前放化疗后对局部晚期直肠癌的辅助化疗(ADORE):一项开放性,多中心,2期,随机对照试验
机译:性与妇科癌症:一项随机对照试验,旨在评估团体心理教育干预措施对经放射治疗的妇科癌症妇女改善性健康的有效性
机译:英国TACT2随机试验(CRUK / 05/19):加速与标准表柔比星联合环磷酰胺甲氨蝶呤氟尿嘧啶或卡培他滨作为乳腺癌的辅助治疗:一项多中心3期开放标签随机对照试验
机译:随机英国TaCT2试验(CRUK / 05/19)加速与标准表柔比星接着环磷酰胺,甲氨蝶呤和氟尿嘧啶或卡培他滨作为乳腺癌的辅助治疗:多中心,3期,开放标签,随机对照试验